ONI’s $75 Million Series B Funding Round

Wilson Sonsini Goodrich & Rosati advised ONI on the deal.ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its desktop…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here